Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for RXST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 263.34M
March 31, 2026 267.30M
December 31, 2025 275.68M
September 30, 2025 275.97M
June 30, 2025 278.01M
March 31, 2025 279.32M
December 31, 2024 281.24M
September 30, 2024 277.26M
June 30, 2024 275.21M
March 31, 2024 163.93M
December 31, 2023 160.36M
Date Value
September 30, 2023 161.48M
June 30, 2023 157.19M
March 31, 2023 145.01M
December 31, 2022 89.90M
September 30, 2022 95.96M
June 30, 2022 109.99M
March 31, 2022 123.16M
December 31, 2021 138.24M
September 30, 2021 150.89M
June 30, 2021 40.27M
March 31, 2021 52.22M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Precision Optics Corp., Inc. 20.11M
Alcon AG 21.60B
The Cooper Cos., Inc. 8.239B
UFP Technologies, Inc. 462.42M
TransMedics Group, Inc. 518.05M

Shareholders Equity (Quarterly) Related Metrics